Search research articles
Contact Us
Filters
Showing results (11-20 of 298) with videos related to
Page
of 30
Sort By:
The New England Journal of Medicine
|
July 24, 2014
Parallels between cancer and infectious disease
Richard S Hotchkiss, Lyle L Moldawer
Critical Care Medicine
|
December 17, 2016
Sepsis Diagnostics: From Discovery to Application
Juan C Mira, Lyle L Moldawer
Expert Opinion on Therapeutic Targets
|
February 1, 2014
HMGB1 as a therapeutic target for sepsis: it's all in the timing!
Lori F Gentile, Lyle L Moldawer
Future Microbiology
|
March 28, 2008
Using innate immunity to characterize the host response to microbial invasion in severe sepsis
Elizabeth A Warner, Lyle L Moldawer
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|
January 28, 2006
The origins of cachexia in acute and chronic inflammatory diseases
Matthew J Delano, Lyle L Moldawer
Intensive Care Medicine
|
May 4, 2012
Myeloid-derived suppressor cells in sepsis: friend or foe?
Alex G Cuenca, Lyle L Moldawer
The Journal of Burn Care & Rehabilitation
|
April 20, 2004
Cytokines and wound healing: the role of cytokine and anticytokine therapy in the repair response
Philip A Efron, Lyle L Moldawer
Critical Care Medicine
|
December 13, 2005
Biology of interleukin-10 and its regulatory roles in sepsis syndromes
Philip O Scumpia, Lyle L Moldawer
Critical Care Medicine
|
January 13, 2005
Human leukocyte antigen expression in sepsis: what have we learned?
Sven K Tschoeke, Lyle L Moldawer
Critical Care Medicine
|
April 18, 2009
Magic bullets and surrogate biomarkers circa 2009
Matthew J Delano, Lyle L Moldawer
Page
of 30
Search research articles
Search
Showing results (11-20 of 298) with videos related to
Sort By:
Page
of 30
The New England Journal of Medicine
|
July 24, 2014
Parallels between cancer and infectious disease
Richard S Hotchkiss, Lyle L Moldawer
Critical Care Medicine
|
December 17, 2016
Sepsis Diagnostics: From Discovery to Application
Juan C Mira, Lyle L Moldawer
Expert Opinion on Therapeutic Targets
|
February 1, 2014
HMGB1 as a therapeutic target for sepsis: it's all in the timing!
Lori F Gentile, Lyle L Moldawer
Future Microbiology
|
March 28, 2008
Using innate immunity to characterize the host response to microbial invasion in severe sepsis
Elizabeth A Warner, Lyle L Moldawer
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|
January 28, 2006
The origins of cachexia in acute and chronic inflammatory diseases
Matthew J Delano, Lyle L Moldawer
Intensive Care Medicine
|
May 4, 2012
Myeloid-derived suppressor cells in sepsis: friend or foe?
Alex G Cuenca, Lyle L Moldawer
The Journal of Burn Care & Rehabilitation
|
April 20, 2004
Cytokines and wound healing: the role of cytokine and anticytokine therapy in the repair response
Philip A Efron, Lyle L Moldawer
Critical Care Medicine
|
December 13, 2005
Biology of interleukin-10 and its regulatory roles in sepsis syndromes
Philip O Scumpia, Lyle L Moldawer
Critical Care Medicine
|
January 13, 2005
Human leukocyte antigen expression in sepsis: what have we learned?
Sven K Tschoeke, Lyle L Moldawer
Critical Care Medicine
|
April 18, 2009
Magic bullets and surrogate biomarkers circa 2009
Matthew J Delano, Lyle L Moldawer
Page
of 30